Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer

Published:2011-02 Issue:2 Volume:98 Page:261-264
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Morak Marjolein J.M.,Richel Dick J.,van Eijck Casper H.J.,Nuyttens Joost J.M.E.,van der Gaast Ate,Vervenne Walter L.,Padmos Esther E.,Schaake Eva E.,Busch Olivier R.C.,van Tienhoven Geertjan

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference33 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Preoperative evaluation of pancreatic adenocarcinoma;Parsons;J Hepatobiliary Pancreat Surg,2008

3. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000rads) radiation alone, moderate dose radiation (4000rads+5-fluorouracil), and high dose radiation+5-fluorouracil: the Gastrointestinal Tumor Study Group;Moertel;Cancer,1981

4. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer;Morganti;Ann Surg Oncol,2010

5. Management of locally advanced adenocarcinoma of the pancreas;Ryan;Hematol Oncol Clin North Am,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study;Współczesna Onkologia;2024

2. Repurposing radiosensitising medicines for radiotherapy: an overview;BMJ Oncology;2024-01

3. Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125 I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial;International Journal of Urology;2020-06-26

4. Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial);EClinicalMedicine;2019-12

5. Inflammation-Related Pancreatic Carcinogenesis;Pancreas;2017-09